prof. Sylvie Rottey

Weekly vs 3-weekly cisplatin : a retrospective cohort study

Michael Saerens (UGent) , Alexander Van den Broeck, Geertrui Van de Weghe, Wouter Huvenne (UGent) , Peter Tomassen (UGent) , Wouter Bauters (UGent) , Tijl Vermassen (UGent) , Sarah Deschuymer (UGent) , Sylvie Rottey (UGent) and Fréderic Duprez (UGent)

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 192(Supplement 1). p.S280-S283

Add to list

Journal Article
A1
open access

Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

Daan De Maeseneer (UGent) , Pieter De Visschere (UGent) , Mats Van den broecke, Felix Delbare, Geert Villeirs (UGent) , Sofie Verbeke (UGent) , Valerie Fonteyne (UGent) , Charles Van Praet (UGent) , Karel Decaestecker (UGent) , Alexander Decruyenaere (UGent) , et al.

(2024) BMC MEDICAL IMAGING. 24(1).

Add to list

Journal Article
A1
open access

The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer

Tijl Vermassen (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Nico Callewaert (UGent) , Joris Delanghe (UGent) and Sylvie Rottey (UGent)

(2024) BIOMEDICINES. 12(5).

Add to list

Journal Article
A1
open access

Potential clinical applications of current and future oral forms of desmopressin (review)

Karel Everaert (UGent) , Tove Holm-Larsen (UGent) , George Bou Kheir (UGent) , Sylvie Rottey (UGent) , Jeffrey Weiss, Johan Vande Walle (UGent) , Abdo Kabarriti, Lien Dossche (UGent) , François Hervé (UGent) , Anne-Françoise Spinoit (UGent) , et al.

(2024) EXPERIMENTAL AND THERAPEUTIC MEDICINE. 28(2).

Add to list

Challenges in performing clinical trials in low incidence disease

Levi Hoste (UGent) and Sylvie Rottey (UGent)

(2024) 2024 Symposium : Drug Development from Bench to Bedside @UZGENT, Abstracts.

Add to list

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study

Tijl Vermassen (UGent) , Stijn De Keukeleire (UGent) , Michael Saerens (UGent) , Sylvester Heerwegh, Jens Debacker (UGent) , Wouter Huvenne (UGent) , Philippe Deron (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) , Sylvie Rottey (UGent) , et al.

(2024) EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 281(6). p.2993-3004

Add to list

Journal Article
A1
open access

Infrared spectroscopy : a new frontier in hematological disease diagnosis

Charlotte Delrue, Reinhart Speeckaert (UGent) , Matthijs Oyaert (UGent) , Tessa Kerre (UGent) , Sylvie Rottey (UGent) , Renaat Coopman (UGent) , Wouter Huvenne (UGent) , Sander De Bruyne and Marijn Speeckaert (UGent)

(2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(23).

Add to list

Single ascending doses of REGN7999, a monoclonal antibody inhibitor of TMPRSS6, increase serum hepcidin and cause deep, sustained reductions in serum iron in healthy human volunteers

Sylvie Rottey (UGent) , Nikhil Singh, Emily Labriola-Tompkins, Heinrich E Lob, Kusha Mohammadi, Hazem Hassan, Lorna Farrelly, Swati Duggal, Harvey Chin, Sarah Hatsell, et al.

(2023) BLOOD. In Blood 142(Supplement 1). p.3841-3841

Add to list

Phase I, non-randomised, open-label, multi-centre dose escalation trial of BI 764532 (DLL3/CD3 IgG-like T cell engager [TcE]) plus ezabenlimab (anti-PD-1 antibody) in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs) expressing DLL3

J. Mazieres, M. Duruisseaux, H. Curcio, C. Morizane, R. Galot, Sylvie Rottey (UGent) , J. A. Stratmann, Y. Ma, M. Bouzaggou, L. Geng, et al.

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S1076-S1077

Add to list

GeNeo : agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative

P. G. Aftimos, K. Punie, L. Decoster, C. Van Marcke de Lummen, A. Hebrant, G. Raicevic, E. Van Valckenborgh, B. Maes, J. Maetens, J. J. Collignon, et al.

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S253-S254

Academic Bibliography

prof. Sylvie Rottey

Weekly vs 3-weekly cisplatin : a retrospective cohort study

Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer

Potential clinical applications of current and future oral forms of desmopressin (review)

Challenges in performing clinical trials in low incidence disease

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study

Infrared spectroscopy : a new frontier in hematological disease diagnosis

Single ascending doses of REGN7999, a monoclonal antibody inhibitor of TMPRSS6, increase serum hepcidin and cause deep, sustained reductions in serum iron in healthy human volunteers

Phase I, non-randomised, open-label, multi-centre dose escalation trial of BI 764532 (DLL3/CD3 IgG-like T cell engager [TcE]) plus ezabenlimab (anti-PD-1 antibody) in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs) expressing DLL3

GeNeo : agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative

Contents

Support

Contact